Ann Lab Med.  2025 Jan;45(1):70-76. 10.3343/alm.2024.0159.

Evaluation of the Disk Diffusion Test for Bacteroides fragilis Group Clinical Isolates

• Lee Y
• Bae MH
• Lee H
• Kim M
• Lee K

• KMID: 2563857
• DOI: http://doi.org/10.3343/alm.2024.0159

Abstract

Background
Bacteroides fragilis group (BFG) isolates are the most frequently isolated gram-negative anaerobic bacteria and exhibit higher levels of antimicrobial resistance than other anaerobic bacteria. Reliable susceptibility testing is needed because of reports of resistance to the most active antibiotics. Recently, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) introduced disk zone diameter breakpoints. We evaluated the disk diffusion test (DDT) for susceptibility testing of BFG isolates compared with the agar dilution method.
Methods
In total, 150 BFG isolates were collected from three institutes in Korea. The agar dilution method was conducted according to the CLSI guidelines. DDT was performed following the EUCAST guideline. Fastidious anaerobe agar supplemented with 5% defibrinated horse blood was used as the culture medium. Nine antimicrobials were evaluated: penicillin, cefoxitin, cefotetan, imipenem, meropenem, piperacillin-tazobactam, clindamycin, moxifloxacin, and metronidazole.
Results
The categorical agreement (CA) between the two methods was > 90.0% for imipenem, meropenem, clindamycin, and metronidazole. However, the CA for piperacillintazobactam was low, at 83.2%. Major errors were found: 5.4% for imipenem, 7.4% for meropenem, and 12.8% for piperacillin-tazobactam. All minor errors were < 10%. We propose using the area of technical uncertainty (ATU) zone-overlapping area for susceptible and resistant strains to reduce errors in the DDT. Outside the ATU, the CAs of cefoxitin, cefotetan, and piperacillin-tazobactam were > 90.0%, whereas that of moxifloxacin was increased to 88.5%.
Conclusions
The DDT can be a useful alternative antimicrobial susceptibility test for BFG isolates when using the ATU zone to reduce errors.

Keyword

Area of technical uncertainty; Bacteroides fragilis; Disk diffusion antimicrobial tests; Microbial sensitivity tests; Uncertainty

Figure

• 

  Fig. 1 Distribution of inhibition zone diameters and MICs of 149 BFG isolates for nine antibiotics. The numbers in the figures represent isolate counts. Red letters on the axis represent MIC or zone diameter breakpoints for resistance. Solid black and dashed lines represent CLSI MIC values for resistance and intermediate resistance, respectively. Dash-dot lines indicate EUCAST MIC values for resistance (A–I). Red vertical lines represent zone diameter breakpoints for resistance (A–F). The gray zone represents the ATU in this study (G–I). Abbreviations: BFG, B. fragilis group; MIC, minimum inhibitory concentration; EUCAST, European Committee on Antimicrobial Susceptibility Testing; ATU, area of technical uncertainty.

Reference

References

1. Nagy E, Boyanova L, Justesen US. ESCMID Study Group of Anaerobic Infections. 2018; How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories. Clin Microbiol Infect. 24:1139–48. DOI: 10.1016/j.cmi.2018.02.008. PMID: 29458156.

2. Fang H, Li X, Yan MK, Tong MK, Chow KH, Cheng VC, et al. 2023; Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021. Anaerobe. 82:102756. DOI: 10.1016/j.anaerobe.2023.102756. PMID: 37429411.

3. Dubreuil LJ. 2024; Fifty years devoted to anaerobes: historical, lessons, and highlights. Eur J Clin Microbiol Infect Dis. 43:1–15. DOI: 10.1007/s10096-023-04708-4. PMID: 37973693.

4. Lee Y, Park Y, Kim MS, Yong D, Jeong SH, Lee K, et al. 2010; Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea. Antimicrob Agents Chemother. 54:3993–7. DOI: 10.1128/AAC.00481-10. PMID: 20585132. PMCID: PMC2935019.

5. Byun JH, Kim M, Lee Y, Lee K, Chong Y. 2019; Antimicrobial susceptibility patterns of anaerobic bacterial clinical isolates from 2014 to 2016, including recently named or renamed species. Ann Lab Med. 39:190–9. DOI: 10.3343/alm.2019.39.2.190. PMID: 30430782. PMCID: PMC6240532.

6. Nagy E, Urban E, Nord CE. ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. 2011; Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect. 17:371–9. DOI: 10.1111/j.1469-0691.2010.03256.x. PMID: 20456453.

7. Matuschek E, Brown DF, Kahlmeter G. 2014; Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 20:O255–66. DOI: 10.1111/1469-0691.12373. PMID: 24131428.

8. Nagy E, Justesen US, Eitel Z, Urban E. ESCMID Study Group on Anaerobic Infection. 2015; Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates. Anaerobe. 31:65–71. DOI: 10.1016/j.anaerobe.2014.10.008. PMID: 25464140.

9. Bavelaar H, Justesen US, Morris TE, Anderson B, Copsey-Mawer S, Stubhaug TT, et al. 2021; Development of a EUCAST disk diffusion method for the susceptibility testing of rapidly growing anaerobic bacteria using fastidious anaerobe agar (FAA): a development study using Bacteroides species. Clin Microbiol Infect. 27:1695.e1–6. DOI: 10.1016/j.cmi.2021.03.028. PMID: 33813129.

10. CA-SFM, Comité de l'antibiogramme. Recommandations, Société Française de Microbiologie. Recommandations, Société Française de Microbiologie. https://www.sfm-microbiologie.org/wp-content/uploads/2020/07/casfm_2011.pdf. Updated on Jul 2020.

11. Dubreuil L. Members of the CA-SFM 2019. 2020; Improvement of a disk diffusion method for antibiotic susceptibility testing of anaerobic bacteria. French recommendations revisited for 2020. Anaerobe. 64:102213. DOI: 10.1016/j.anaerobe.2020.102213. PMID: 32615269.

12. EUCAST. Disk diffusion anaerobic bacteria. https://www.eucast.org/ast_of_bacteria/disk_diffusion_methodology. Updated on Jan 2023.

13. CLSI. 2012. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved guideline. 8th ed. Clinical and Laboratory Standards Institute;Wayne, PA: M11-A8. DOI: 10.1093/clinids/6.supplement_1.s242.

14. EUCAST, Reading guide for disk diffusion for selected rapidly growing anaerobic bacteria on fastidious anaerobe agar with 5% horse blood (FAA-HB). https://www.eucast.org/ast_of_bacteria/disk_diffusion_methodology. Updated on Jan 2023.

15. Federal drug administration. Guidance for industry and FDA class II special controls guidance document: antimicrobial susceptibility test systems. https://www.fda.gov/media/88069. Updated on Aug 2009.

16. CLSI. 2023. Development of in vitro susceptibility test methods, breakpoints, and quality control parameters; approved guideline. 6th ed. Clinical and Laboratory Standards Institute;Wayne, PA: M23-ED6.